IRIDEX Corporation (IRIX)Healthcare | Medical Devices | Mountain View, United States | NasdaqCM
1.06 USD
+0.01
(0.483%)
⇧
(April 21, 2026, 10:36 a.m.
EDT)
Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 18, 2026, 11:29 p.m. EDT
IRIX is suffering from a severe profitability crisis (negative EBIT and ROE) and is a pure momentum stock with questionable fundamentals, though the CFO buying is a positive internal signal. The balance sheet is intact, but the long-term trajectory is weak; this is a high-risk speculative micro-cap play rather than a core holding. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.107560 |
| AutoARIMA | 0.117631 |
| MSTL | 0.123503 |
| AutoTheta | 0.232507 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 21% |
| H-stat | 40.18 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.002 |
| Excess Kurtosis | 0.35 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 92.076 |
| Revenue per Share | 3.111 |
| Market Cap | 18,347,574 |
| Forward P/E | Infinity |
| Beta | 0.76 |
| Profit Margins | -8.42% |
| Website | https://www.iridex.com |
As of April 18, 2026, 11:29 p.m. EDT: Options activity is extremely thin with negligible volume. In the July 2026 expiry, there is significant put open interest (18 contracts) at the $2.50 strike relative to near-term call activity, despite both sides having near-zero valuation. This disproportionate strike positioning (135.8% vol increase at $2.50) coupled with zero call volume suggests a speculative 'deny' strategy or a long-dated positioning play rather than a trapped-short covering signal. The lack of specific directional flow in the near term indicates neutral to slightly bearish sentiment, but with insufficient data to confirm a trend.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.03669727 |
| Address1 | 1,212 Terra Bella Avenue |
| All Time High | 18.5 |
| All Time Low | 0.36 |
| Ask | 1.35 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 1,258,690 |
| Average Daily Volume3 Month | 271,891 |
| Average Volume | 271,891 |
| Average Volume10Days | 1,258,690 |
| Beta | 0.764 |
| Bid | 0.7632 |
| Bid Size | 2 |
| Book Value | -0.062 |
| City | Mountain View |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.0601 |
| Current Ratio | 1.912 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.08 |
| Day Low | 1.06 |
| Debt To Equity | 92.076 |
| Display Name | IRIDEX |
| Earnings Call Timestamp End | 1,774,558,800 |
| Earnings Call Timestamp Start | 1,774,558,800 |
| Earnings Timestamp | 1,774,555,200 |
| Earnings Timestamp End | 1,778,616,000 |
| Earnings Timestamp Start | 1,778,616,000 |
| Ebitda | -2,320,000 |
| Ebitda Margins | -0.04404 |
| Enterprise To Ebitda | -9.774 |
| Enterprise To Revenue | 0.431 |
| Enterprise Value | 22,676,772 |
| Eps Current Year | -0.12 |
| Eps Forward | 0.0 |
| Eps Trailing Twelve Months | -0.26 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 650 940 4710 |
| Fifty Day Average | 1.2616 |
| Fifty Day Average Change | -0.20150006 |
| Fifty Day Average Change Percent | -0.15971786 |
| Fifty Two Week Change Percent | -3.6697268 |
| Fifty Two Week High | 1.65 |
| Fifty Two Week High Change | -0.5899 |
| Fifty Two Week High Change Percent | -0.35751516 |
| Fifty Two Week Low | 0.87 |
| Fifty Two Week Low Change | 0.19009995 |
| Fifty Two Week Low Change Percent | 0.2185057 |
| Fifty Two Week Range | 0.87 - 1.65 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 824,481,000,000 |
| Float Shares | 10,949,354 |
| Forward Eps | 0.0 |
| Forward P E | Infinity |
| Free Cashflow | 1,528,125 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.36501 |
| Gross Profits | 19,227,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.29827 |
| Held Percent Institutions | 0.17873 |
| Implied Shares Outstanding | 17,307,401 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://phx.corporate-ir.net/phoenix.zhtml?c=112360&p=irol-irhome |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,398,400 |
| Long Business Summary | IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California. |
| Long Name | IRIDEX Corporation |
| Market | us_market |
| Market Cap | 18,347,574 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_30288 |
| Most Recent Quarter | 1,767,398,400 |
| Net Income To Common | -4,437,000 |
| Next Fiscal Year End | 1,798,934,400 |
| Non Diluted Market Cap | 18,259,308 |
| Number Of Analyst Opinions | 1 |
| Open | 1.08 |
| Operating Cashflow | -2,115,000 |
| Operating Margins | -0.00102 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.94 |
| Phone | 650 940 4700 |
| Previous Close | 1.055 |
| Price Eps Current Year | -8.834167 |
| Price Hint | 4 |
| Price To Book | -17.098387 |
| Price To Sales Trailing12 Months | 0.34831655 |
| Profit Margins | -0.084230006 |
| Quick Ratio | 1.179 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.005100012 |
| Regular Market Change Percent | 0.48341346 |
| Regular Market Day High | 1.08 |
| Regular Market Day Low | 1.06 |
| Regular Market Day Range | 1.06 - 1.08 |
| Regular Market Open | 1.08 |
| Regular Market Previous Close | 1.055 |
| Regular Market Price | 1.0601 |
| Regular Market Time | 1,776,782,210 |
| Regular Market Volume | 41,873 |
| Return On Assets | -0.05514 |
| Return On Equity | -1.26428 |
| Revenue Growth | 0.16 |
| Revenue Per Share | 3.111 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 17,307,401 |
| Shares Percent Shares Out | 0.0019 |
| Shares Short | 32,477 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 45,880 |
| Short Name | IRIDEX Corporation |
| Short Percent Of Float | 0.0023999999 |
| Short Ratio | 0.58 |
| Source Interval | 15 |
| State | CA |
| Symbol | IRIX |
| Target High Price | 2.75 |
| Target Low Price | 2.75 |
| Target Mean Price | 2.75 |
| Target Median Price | 2.75 |
| Total Cash | 6,028,000 |
| Total Cash Per Share | 0.348 |
| Total Debt | 4,532,000 |
| Total Revenue | 52,675,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.26 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.19645 |
| Two Hundred Day Average Change | -0.13635004 |
| Two Hundred Day Average Change Percent | -0.113962166 |
| Type Disp | Equity |
| Volume | 41,873 |
| Website | https://www.iridex.com |
| Zip | 94,043 |